21Oct/14
Camstar-Siemens

Siemens’ Acquisition of Camstar Could Help Med-Tech Companies Close the Loop on Product Quality

By Daniel R. Matlis

Siemens’ acquisition of Camstar could help Medical Technology (Med-Tech) companies improve product quality by providing integrated solutions to manage Medical Devices across the Total Product Life Cycle (TPLC). The Camstar acquisition builds on Siemens’ industrial digitalization strategy by broadening its integrated product development and production automation. Continue reading

12Oct/14
Image courtesy of Siemens

J&J – Siemens Collaborate on Personalized Medical Device Platform

By Daniel R. Matlis

Modern Healthcare is shifting to personalized care tailored to each patient’s anatomy, therapeutic regimen and expectations. As a result, Med-Tech companies are seeking new ways to develop, design and manufacture more personalized devices that improve patient outcomes while increasing quality of care and reducing Healthcare costs.

To address this need, Siemens and Johnson & Johnson’s DePuy Synthes Joint Reconstruction division leveraged the Personalized Product Innovation platform to develop the TRUMATCH® Personalized Solutions. Continue reading

23Sep/14
Picture courtesy ofIBM

IBM puts Watson to work at Johnson & Johnson and Sanofi R&D

By Ellyn McMullin, Research Associate, Axendia, Inc.

Three years after its victory on the TV quiz show Jeopardy! IBM Watson has evolved to represent a new era of computing. Today, Watson is no longer just the world’s most famous game-playing computer. IBM has put Watson to work in various industries. In healthcare, IBM is co-developing an application with Memorial Sloan-Kettering Cancer Center, and partnering with WellPoint, the University of Texas MD Anderson Cancer Center, and the Cleveland Clinic Lerner College of Medicine.
IBM announced that it is putting Watson to work in Pharma R&D at Johnson & Johnson and Sanofi. Continue reading

02Sep/14
Regulatory -Insight

What Changes Should Manufacturers Expect From FDA?

By Daniel R. Matlis

I recently had the privilege to moderate a panel entitled: “Outlook for the Medical Device Industry 2014 and Beyond: Advice from Proactive Leaders” at Camstar’s 2014 Global Conference. The panel included Vice Presidents of Operations from Advanced Bionics, ConforMIS and Terumo Cardiovascular Group.

In this, the third and final in our series of articles, we share insights and perspective from these executives addressing Regulatory issues impacting the future of the Med Tech industry. Continue reading